Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors

减少颗粒物对老年人心血管健康的影响

基本信息

  • 批准号:
    10427306
  • 负责人:
  • 金额:
    $ 52.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-06-06 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Fine particulate matter <2.5 µm (PM2.5) air pollution is the fifth leading risk factor for mortality worldwide. Over 88 thousand deaths per year are attributable to PM2.5 in the US alone, with the largest portion from cardiovascular (CV) causes (myocardial infarctions, strokes, heart failure). Despite improvements across the US, PM2.5 remains above World Health Organization Air Quality Guidelines (<10 µg/m3) in numerous hot-spots (e.g., near roadways). Therefore, it is critical to develop feasible and effective personal strategies to protect “vulnerable” (urban/near-roadway) and “susceptible” (elderly) populations at risk from the harmful effects of PM2.5. Emerging trials have shown that portable indoor air filtration units (AFUs) with high-efficiency particulate arrestance filters can reduce PM2.5 exposures by 30-50% and improve CV health endpoints (e.g., BP, vascular function). Our recent clinical trial results confirm that even low PM2.5 levels pose significant risks to CV health and that portable indoor air filtration units (AFUs) represent a promising preventative strategy. However, no study has addressed whether exposure reductions and health improvements can be sustained over more clinically relevant periods of intervention (i.e., several weeks) which are required to plausibly yield decreases in actual CV events. In addition, the efficacy of the novel practical (i.e., less expensive and more feasible in real- world settings) approach of using a single AFU only in the bedroom to focus on reducing nocturnal PM2.5 exposure is currently unknown. This proposal seeks to conduct a randomized double-blind 3-way crossover intervention study (AFUs in 2 rooms vs. bedroom AFU use alone vs. sham filtration) in 50 adults living in a low-income senior residence impacted by roadway pollutants. Specific Aims are: (1) determine if long-term, 2-room AFU usage provides sustained reductions in PM2.5 exposure and persistent improvements in cardiometabolic outcomes; (2) determine if nocturnal PM2.5 exposure reduction alone improves cardiometabolic outcomes; and (3) demonstrate the key role of adrenal activation as a novel mechanism explaining PM2.5-induced cardiometabolic changes. Our proposal will help validate the benefits of novel strategies to employ AFUs in an elderly vulnerable population. Positive results would represent a key step in forming the evidence base required to promote more wide-scale AFU use; in the long term, given their low cost and burden, AFU use could be up- scaled to help protect diverse populations.
项目总结/摘要 <2.5 µm的细颗粒物(PM2.5)空气污染是全球第五大死亡风险因素。 仅在美国,每年就有超过8.8万人死于PM2.5,其中最大部分来自 心血管(CV)原因(心肌梗塞、中风、心力衰竭)。尽管各地都有改善, 在美国,PM2.5在许多热点地区仍高于世界卫生组织空气质量指南(<10 µg/m3) (e.g.,公路附近)。因此,制定切实有效的个人保护策略至关重要 “易受伤害”(城市/道路附近)和“易受影响”(老年人)人口, PM2.5。 新兴的试验表明,具有高效颗粒的便携式室内空气过滤装置(AFU) 过滤器可以将PM2.5暴露减少30-50%,并改善CV健康终点(例如,血压,血管 函数)。我们最近的临床试验结果证实,即使是低PM2.5水平也会对CV健康构成重大风险 便携式室内空气过滤装置(AFU)是一种很有前途的预防策略。但没有 一项研究探讨了暴露减少和健康改善是否可以持续更长时间, 临床相关的干预期(即,几周),这需要合理地产生减少, 实际CV事件。此外,新的实用(即,更便宜,更可行的真实的- 世界设置)的方法,仅在卧室使用单个AFU,专注于减少夜间PM2.5 目前暴露情况未知。 本提案旨在进行一项随机双盲3向交叉干预研究(AFU在2 房间与卧室AFU单独使用与假过滤),在50名居住在低收入老年人住宅的成年人中进行 受到道路污染物的影响。具体目的是:(1)确定长期使用2室AFU是否提供 持续减少PM2.5暴露和持续改善心脏代谢结果;(2) 确定单独减少夜间PM2.5暴露是否能改善心脏代谢结果;以及(3) 证明肾上腺激活作为解释PM2.5诱导的心脏代谢的新机制的关键作用。 变化我们的建议将有助于验证在老年人中使用AFU的新策略的益处。 弱势群体。积极的结果将是形成所需证据基础的关键一步, 促进更广泛的AFU使用;从长远来看,由于其成本低,负担轻,AFU的使用可能会增加- 以帮助保护不同的人群。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cardiometabolic Risk Factor Control During Times of Crises and Beyond.
Limitations in the Methodology Assessing Blood Pressure and the Need for Strict Exclusion Criteria-Reply.
评估血压方法的局限性和严格排除标准的必要性-答复。
  • DOI:
    10.1001/jamainternmed.2018.7483
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    39
  • 作者:
    Brook,RobertD;Morishita,Masako
  • 通讯作者:
    Morishita,Masako
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert Daniel Brook其他文献

Robert Daniel Brook的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert Daniel Brook', 18)}}的其他基金

ACHIEVE P1 - HTN
实现 P1 - HTN
  • 批准号:
    10494198
  • 财政年份:
    2021
  • 资助金额:
    $ 52.75万
  • 项目类别:
ACHIEVE P1 - HTN
实现 P1 - HTN
  • 批准号:
    10437396
  • 财政年份:
    2021
  • 资助金额:
    $ 52.75万
  • 项目类别:
ACHIEVE P1 - HTN
实现 P1 - HTN
  • 批准号:
    10662512
  • 财政年份:
    2021
  • 资助金额:
    $ 52.75万
  • 项目类别:
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors
减少颗粒物对老年人心血管健康的影响
  • 批准号:
    10207776
  • 财政年份:
    2014
  • 资助金额:
    $ 52.75万
  • 项目类别:
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors
减少颗粒物对老年人心血管健康的影响
  • 批准号:
    10011861
  • 财政年份:
    2014
  • 资助金额:
    $ 52.75万
  • 项目类别:
COUNTERACT Supplement--ASPIRE: Air Pollution: Strategies for Personalized Intervention to Reduce Exposure
COUNTERACT 补充--ASPIRE:空气污染:减少接触的个性化干预策略
  • 批准号:
    10218398
  • 财政年份:
    2011
  • 资助金额:
    $ 52.75万
  • 项目类别:
ASPIRE: Air Pollution: Strategies for Personalized Intervention to Reduce Exposure
ASPIRE:空气污染:减少接触的个性化干预策略
  • 批准号:
    9754146
  • 财政年份:
    2011
  • 资助金额:
    $ 52.75万
  • 项目类别:
CARDIOVASCULAR LINKAGE BETWEEN ENDOTHELIAL FUNCTION & AIR POLLUTION
内皮功能之间的心血管联系
  • 批准号:
    7603730
  • 财政年份:
    2007
  • 资助金额:
    $ 52.75万
  • 项目类别:
VASCULAR TISSUE ANGIOTENSINII & ENDOTHELIAL DYSFUNCTION IN UNCOMPLICATED OBESITY
血管组织血管紧张素II
  • 批准号:
    7376511
  • 财政年份:
    2006
  • 资助金额:
    $ 52.75万
  • 项目类别:
CARDIOVASCULAR LINKAGE BETWEEN ENDOTHELIAL FUNCTION & AIR POLLUTION
内皮功能之间的心血管联系
  • 批准号:
    7376546
  • 财政年份:
    2006
  • 资助金额:
    $ 52.75万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.75万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 52.75万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.75万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.75万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 52.75万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.75万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.75万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.75万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 52.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 52.75万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了